Search clinical trials for: Monatide (IMS 3015)

Total 3544 results

ADC Therapeutics S.A.

Completed

Study of ADCT-301 in Patients With Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma

Hodgkin Lymphoma | Non-Hodgkin Lymphoma

United States, United Kingdom
Alaunos Therapeutics
Memorial Sloan Kettering Cancer Center

Unknown

Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Duke University
Case Western Reserve University

Recruiting

Diaphragm Function and Diver Endurance

Respiratory Muscles

United States
Medibiofarma S.L.

Completed

Study to Assess the Safety and Tolerability of MBF-015 in Healthy Young Volunteers

Safety and Pharmacokinetic

Spain
ADC Therapeutics S.A.

Completed

Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma

Refractory Hodgkin Lymphoma | Relapsed Hodgkin Lymphoma

United States, Spain, United Kingdom, Poland, Belgium, Hungary, Germany, France, Italy, Czechia, Canada
Gwynn Long, M.D.
ADC Therapeutics S.A.

Terminated

ADCT-301 in Patients With R/R AML, MDS, or MDS/MPN

Acute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS) | Myeloproliferative Neoplasm (MDS/MPN)

United States
University of Athens

Recruiting

Effect of Face Mask on Exhaled Carbon Monoxide of Smokers

Concentration of Exhaled Carbon Monoxide

Greece
Queen's University
The Physicians' Services Incorporated Foundation

Terminated

Study of Inhaling Carbon Monoxide to Treat Patients With Intestinal Paralysis After Colon Surgery.

Ileus

Canada
Glenmark Specialty S.A.

Completed

Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR) (GSP 301-303)

Perennial Allergic Rhinitis

United States
Xanthus Pharmaceuticals, Inc.

Completed

Study of Individualized Amonafide to Treat Prostate Cancer

Prostate Cancer

United States
FibroGen

Completed

Safety and Tolerability Study of FG-3019 in Participants With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

United States
HDT Bio
Kaiser Permanente; Rainier Clinical Research Center; C3 Research Associates

Active, not recruiting

Safety And Immunogenicity Of HDT-301 Targeting A SARS-CoV-2 Variant Spike Protein

SARS-CoV2 Infection

United States
Ocera Therapeutics

Completed

Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome

Irritable Bowel Syndrome

United States, Belgium
Medigen Biotechnology Corporation

Completed

A Phase I Study to Evaluate the Safety, Reactogenicity, and Humoral Immune Responses to an Inactivated H5N1 Influenza Vaccine

Avian Influenza | Bird Flu | Influenza A(H5N1)

Taiwan
Scholar Rock, Inc.

Completed

An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy (TOPAZ)

Neuromuscular Diseases | Neuromuscular Manifestations | Atrophy | Muscular Atrophy | Spinal Muscular Atrophy | Muscular Atrophy, Spinal | Spinal Muscular Atrophy Type 3 | SMA | Spinal Muscular Atrophy Type 2

United States, Spain, Italy, Netherlands
Kantonsspital Aarau

Unknown

aICP in Glaucoma and Papilledema (aICP Ophtha)

Open-angle Glaucoma | Papilledema

Switzerland
Cedars-Sinai Medical Center

Not yet recruiting

End Tidal Carbon Monoxide (ETCO): - A Tool to Aid Identification of Neonatal Hemolysis

Neonatal Jaundice | End Tidal Carbon Monoxide Excretion as a Diagnostic Tool for Hemolysis in the Newborn | End Tidal Carbon Monoxide
Centre Hospitalier Universitaire de Besancon

Unknown

Assessment of Cardiac Output With EtCO2 (COCO2)

Cardiac Output

France
Medtronic Cardiovascular

Completed

Medtronic HAMMOCK Post Approval Study

Heart Valve Diseases

United States, Germany, Poland
Kibow Pharma

Recruiting

Rollover Extension Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With CKD IV Completing The US-APR2020-01 Study

Chronic Kidney Disease stage4

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults

Influenza

United States
Jennifer Marler, MD
UserWise, LLC

Completed

Pivot Breath Sensor Performance Study

Smoking Cessation | Smoking, Tobacco

United States
Jonsson Comprehensive Cancer Center

Withdrawn

Compassionate Single Subject Use of FG-3019 (FibroGen) in Locally Advanced, Unresectable Pancreatic Cancer

Pancreatic Cancer
NexEos Diagnostics, Inc.

Recruiting

A Study to Investigate Safety and Tolerability of NDX-3315 and NDX-3324 in Healthy Participants and Patients With Eosinophilic Esophagitis

Eosinophilic Esophagitis

United States
Dong-A ST Co., Ltd.
Meiji Seika Pharma Co., Ltd.

Completed

Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque Psoriasis (Opportuniti)

Moderate to Severe Chronic Plaque Psoriasis

United States
FibroGen

Completed

A Phase 1 Study of Safety and Bioactivity With FG-3019 in Combination With Gemcitabine and Erlotinib for Subjects With Locally Advanced or Metastatic Pancreatic Cancer

Locally Advanced or Metastatic Pancreatic Cancer

United States
University Hospital, Montpellier

Terminated

Impact of Twice-daily Measurement of Expired CO During Hospitalization on Smoking (CoCHU)

Smoking | Hospitalization

France
Johns Hopkins University
Maryland Department of Health and Mental Hygiene

Completed

COach2Quit TRIAL: Assessing a Prototype Personal Carbon Monoxide Monitor for Smoking Cessation (C2Q)

Smoking | Smoking Cessation

United States
Rigshospitalet, Denmark
Herlev Hospital

Completed

Carbon Monoxide-based Rebreathing Method and Bioimpedance in Hemodialysis Patients (HEMOVOL)

Hemodialysis Complication | Volume Overload

Denmark
University of Florida
University of Oklahoma

Completed

Comparison of Smoking and Vaping in Families

Smoking

United States
FibroGen

Terminated

Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis

United States, France, United Kingdom, Korea, Republic of, Lebanon, Denmark, China, Italy, Spain, Serbia, Germany, Netherlands, Czechia, Brazil, Poland, Argentina, Colombia, Dominican Republic, Georgia, Hungary, Ireland, Mexico, Peru, Switzerlan... and more
Washington University School of Medicine
National Cancer Institute (NCI); The Foundation for Barnes-Jewish Hospital; Celldex...

Terminated

Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients

Pancreatic Cancer | Pancreas Cancer | Cancer of the Pancreas

United States
Opsona Therapeutics Ltd.

Completed

Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function

Delayed Graft Function

United States, Spain, Belgium, Switzerland, France, Germany, United Kingdom, Poland, Netherlands, Austria, Czech Republic
RWTH Aachen University

Completed

Reduction of Groin Wound Infections After Vascular Surgery by Using an Incision Management System (IMS) (IMS)

Infections

Germany
Ocugen

Recruiting

A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa (liMeliGhT)

Retinitis Pigmentosa

United States
FibroGen

Active, not recruiting

Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMD (LELANTOS-2)

Duchenne Muscular Dystrophy

United States, Spain, Canada, Australia, China, Italy, Belgium, France, Netherlands, Austria, United Kingdom
Lytix Biopharma AS
ICON plc; Theradex

Completed

LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab

Melanoma | Lymphoma | Cancer | Breast Cancer | Head and Neck Cancer | Triple-Negative Breast Cancer

United Kingdom, France, Norway, Belgium, Italy
FibroGen

Terminated

Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD) (LELANTOS-1)

Duchenne Muscular Dystrophy

United States, Belgium, Israel, Spain, Canada, Australia, Switzerland, United Kingdom, France, China, Netherlands, Italy, Austria, Czechia
Sanofi Pasteur, a Sanofi Company

Completed

Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults

Influenza

United States
Bioray Laboratories
First Affiliated Hospital of Zhejiang University

Recruiting

Universal CAR-T Cells (BRL-301) in Refractory Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE)

China
Scholar Rock, Inc.

Active, not recruiting

Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam (SAPPHIRE)

Neuromuscular Diseases | Neuromuscular Manifestations | Atrophy | Muscular Atrophy | Spinal Muscular Atrophy | Muscular Atrophy, Spinal | Spinal Muscular Atrophy Type 3 | SMA | Spinal Muscular Atrophy Type 2 | Anti-myostatin

United States, Germany, Belgium, Spain, United Kingdom, Netherlands, France, Italy, Poland
Indiana University
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Active, not recruiting

Physiological Phenotyping of Respiratory Outcomes in Infants Born Premature (P3)

Premature Lungs

United States
Brigham and Women's Hospital
Massachusetts General Hospital; Washington University School of Medicine; Duke... and other collaborators

Active, not recruiting

Safety and Efficacy Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)

Acute Respiratory Distress Syndrome

United States
University of Cincinnati
VA Office of Research and Development

Unknown

Exhaled Carbon Monoxide and Red Blood Cell Turnover

Healthy | Diabetes Mellitus

United States
Bioray Laboratories
Shanghai Changzheng Hospital

Recruiting

Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases

Systemic Sclerosis | Sjogren's Syndrome | Antiphospholipid Syndrome | Systemic Lupus Erythematosus (SLE) | ANCA Associated Systemic Vasculitis | Inflammatory Myopathy

China
Consumer Wellness Solutions
Vincere Health; Maryland State Tobacco Quitline

Recruiting

CO Monitoring for Tobacco Cessation in Quitlines

Tobacco Dependence

United States
Antisoma Research

Unknown

A Pharmacokinetic and Efficacy Study of Amonafide L-malate (AS1413) in Combination With Cytarabine in Patients With Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

Ukraine, Georgia
Rigshospitalet, Denmark
Steno Diabetes Center Copenhagen

Completed

Glycaemic Markers in Persons With Type 2 Diabetes on Haemodialysis (GLYCOHEMO)

Type2 Diabetes | Diabetic Nephropathy Type 2

Denmark
Celldex Therapeutics

Terminated

A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs

Chronic Lymphocytic Leukemia (CLL) | Acute Lymphoblastic Leukemia (ALL) | Myelodysplastic Syndrome (MDS) | Acute Myelogenous Leukemia (AML) | Chronic Myelogenous Leukemia (CML) | Non-Hodgkins Lymphoma (NHL) | For Donors | Related Donors Giving Peripheral Blood Stem Cells (PBSC) to a Sibling | For Recipients and other conditions

United States
Memorial Sloan Kettering Cancer Center
ENABLE MEDICINE

Active, not recruiting

Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas

Sarcoma | Leiomyosarcoma | High Grade Sarcoma | Undifferentiated Pleomorphic Sarcoma | Advanced Sarcoma | Myxofibrosarcoma | Dedifferentiated Liposarcoma

United States

Search clinical trials for: Monatide (IMS 3015)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations